Texas Medicaid Designates Pegfilgrastim-cbqv on the Preferred Drug List

For 2021, Texas Medicaid has designated pegfilgrastim-cbqv (Udenyca^®, Coherus Biosciences) the preferred pegfilgrastim on the Preferred Drug List (PDL). Udenyca^® coverage details are available here.

Please contact marketaccess@coherus.com for additional information.

Posted 3/15/2021